(Q43664426)

25 November 2017

Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control (English)

1 reference

25 November 2017

Sözmen EY

1

1 reference

25 November 2017

Sözmen B

series ordinal

2

1 reference

25 November 2017

Delen Y

series ordinal

3

1 reference

25 November 2017

Onat T

series ordinal

4

1 reference

25 November 2017

1 July 2001

1 reference

Archives of Medical Research

25 November 2017

1 reference

25 November 2017

32

1 reference

25 November 2017

4

1 reference

25 November 2017

283-287

1 reference

Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

A simple method for determination of serum catalase activity and revision of reference range

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Glycation impairs high-density lipoprotein function

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

Oxidative damage in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900285-5

7 January 2021

10.1016/S0188-4409(01)00285-5

Identifiers

DOI

1 reference

25 November 2017

1 reference